Bingfang Yan

8PUBLICATIONS
3CO-AUTHORS
Tissue engineeringCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsVeterinary virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 30, 2025
Hydrogel Conjugation: Engineering of Hydrogels for Drug Delivery.

Linh Dinh, Sung-Joo Hwang, Bingfang Yan

|Jul 30, 2025
Carboxylesterase Factors Influencing the Therapeutic Activity of Common Antiviral Medications Used for SARS-CoV-2 Infection.

Yue Shen, William Eades, Linh Dinh

|Mar 17, 2023
Viral target and metabolism-based rationale for combined use of recently authorized small molecule COVID-19 medicines: Molnupiravir, nirmatrelvir, and remdesivir.

Daisy Yan, Bingfang Yan

|Dec 14, 2022
Covalent CES2 Inhibitors Protect against Reduced Formation of Intestinal Organoids by the Anticancer Drug Irinotecan.

William Eades, William Liu, Yue Shen

|Jul 05, 2022
The COVID-19 Oral Drug Molnupiravir Is a CES2 Substrate: Potential Drug-Drug Interactions and Impact of CES2 Genetic Polymorphism In Vitro.

Yue Shen, William Eades, William Liu

|Nov 15, 2021
The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance.

Daisy Yan, One Hyuk Ra, Bingfang Yan

Pageof 2

Frequent Collaborators

2 joint publications

Linh Dinh

1 joint publications

William Eades

1 joint publications

Sung-Joo Hwang